Abbvie Announces Q4 Dividend of $1.64/Share, Payable Nov 14, 2025
PorAinvest
viernes, 5 de septiembre de 2025, 11:08 am ET1 min de lectura
ABBV--
Since its inception in 2013, AbbVie has increased its dividend by 310 percent, demonstrating its dedication to consistent dividend growth. The company is a member of the S&P Dividend Aristocrats Index, which tracks companies that have annually increased their dividend for at least 25 consecutive years [1][2].
Institutional investors have shown interest in AbbVie's stock, with AQR Capital Management LLC reducing its stake by 46.6% and TD Capital Management LLC increasing its stake by 82.9% during the first quarter of 2025 [3]. Despite the high dividend payout ratio of 312.38%, the company continues to maintain strong financial stability and a focus on shareholder value.
AbbVie's recent earnings report showed earnings per share (EPS) of $2.97 for the quarter, missing analysts' consensus estimates by ($0.27) [3]. The company reported revenue of $15.42 billion during the quarter, up 6.6% year-over-year. AbbVie's strong pipeline and product portfolio continue to drive its financial performance.
Several equities research analysts have rated AbbVie's stock positively, with a consensus rating of "Moderate Buy" and a target price of $214.95 [3]. The company's market capitalization stands at $373.79 billion, with a PE ratio of 100.76 and a beta of 0.53 [3].
References:
[1] https://finance.yahoo.com/news/abbvie-declares-quarterly-dividend-130700697.html
[2] https://www.stocktitan.net/news/ABBV/abb-vie-declares-quarterly-qytl2w19gesy.html
[3] https://www.marketbeat.com/instant-alerts/filing-abbvie-inc-abbv-shares-sold-by-aqr-capital-management-llc-2025-09-04/
[4] https://www.streetinsider.com/Dividends/AbbVie+%28ABBV%29+Declares+%241.64+Quarterly+Dividend%3B+3.1%25+Yield/25301477.html
Abbvie Inc. declared a quarterly cash dividend of $1.64 per share. The dividend is payable on November 14, 2025, to stockholders of record on October 15, 2025.
AbbVie Inc. (NYSE: ABBV) has announced a quarterly cash dividend of $1.64 per share, payable on November 14, 2025, to stockholders of record on October 15, 2025 [1][2][4]. This dividend represents an annualized rate of $6.56 and a yield of 3.1%, reflecting the company's commitment to shareholder returns.Since its inception in 2013, AbbVie has increased its dividend by 310 percent, demonstrating its dedication to consistent dividend growth. The company is a member of the S&P Dividend Aristocrats Index, which tracks companies that have annually increased their dividend for at least 25 consecutive years [1][2].
Institutional investors have shown interest in AbbVie's stock, with AQR Capital Management LLC reducing its stake by 46.6% and TD Capital Management LLC increasing its stake by 82.9% during the first quarter of 2025 [3]. Despite the high dividend payout ratio of 312.38%, the company continues to maintain strong financial stability and a focus on shareholder value.
AbbVie's recent earnings report showed earnings per share (EPS) of $2.97 for the quarter, missing analysts' consensus estimates by ($0.27) [3]. The company reported revenue of $15.42 billion during the quarter, up 6.6% year-over-year. AbbVie's strong pipeline and product portfolio continue to drive its financial performance.
Several equities research analysts have rated AbbVie's stock positively, with a consensus rating of "Moderate Buy" and a target price of $214.95 [3]. The company's market capitalization stands at $373.79 billion, with a PE ratio of 100.76 and a beta of 0.53 [3].
References:
[1] https://finance.yahoo.com/news/abbvie-declares-quarterly-dividend-130700697.html
[2] https://www.stocktitan.net/news/ABBV/abb-vie-declares-quarterly-qytl2w19gesy.html
[3] https://www.marketbeat.com/instant-alerts/filing-abbvie-inc-abbv-shares-sold-by-aqr-capital-management-llc-2025-09-04/
[4] https://www.streetinsider.com/Dividends/AbbVie+%28ABBV%29+Declares+%241.64+Quarterly+Dividend%3B+3.1%25+Yield/25301477.html

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios